RECENT COMMENTS

Rajesh Kumar: Is it helpfull for Overian cancer patient at advance stage? Rajesh Kumar +919681303310   »Read more

Cindy: I'm not a medical professional. My mother has been diagnosed with CUP - and was treated several year [...]   »Read more

Rajesh Kumar: +919681303310.   »Read more

Rajesh Kumar: Please write your comment here   »Read more

christian: Is gabapentin has been proposed to treat peripheric neuropathy induced by chemotherapy. At low dosa [...]   »Read more

 

Article type: Best Cancer Reporter Award

Keywords: Eric Baumann, Best Cancer Reporter Award, brain tumour, Tages-Anzeiger, .

This article has 0 comments

Facebook Twitter Share - Send - Print - Pdf

 

“There’s a shadow in your head”

“There’s a shadow
in your head”

Eric Baumann, a healthy 34-year-old, in love with life and his new girlfriend, had just started as the new London correspondent for the Swiss daily Tages-Anzeiger when he was diagnosed with brain cancer. His description, republished here, of the seven tumultuous days that changed everything, and how he still manages to retain his love of life, won him a Best Cancer Reporter Award.

» Eric Baumann

To read the complete article please click on the pdf icon

 
COMMENTS (0)
When submitted, your comment will be moderated. Messages which may be considered defamatory, which incite hatred or contain foul or abusive language, or are gratuitously offensive, will not be published. Please ensure that your comments are concise and relevant to the topic in question. Off-topic comments and comments without a username will not be published.

ESO reserves the absolute right not to publish comments.
  Name (required)
  E-mail (will not be published) (required)
  Captcha code (required)

CancerWorld invites you to visit:

 
CancerWorld is a pioneering initiative of the European School of Oncology financially supported through Sharing Progress in Cancer Care, a collaborative programme between ESO and Amgen, Celgene, Eisai, Eli Lilly, Genomic Health, GlaxoSmithKline, Merck Serono, Novartis, Roche and Sanofi Aventis.